These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10705409)
21. Surgical excision outcome after radial scar without atypical proliferative lesion on breast core needle biopsy: a single institutional analysis. Hou Y; Hooda S; Li Z Ann Diagn Pathol; 2016 Apr; 21():35-8. PubMed ID: 27040928 [TBL] [Abstract][Full Text] [Related]
22. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings]. Piubello Q; Montemezzi S; D'Atri C Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993 [TBL] [Abstract][Full Text] [Related]
23. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Port ER; Park A; Borgen PI; Morris E; Montgomery LL Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485 [TBL] [Abstract][Full Text] [Related]
24. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy. Rendi MH; Dintzis SM; Lehman CD; Calhoun KE; Allison KH Ann Surg Oncol; 2012 Mar; 19(3):914-21. PubMed ID: 21861212 [TBL] [Abstract][Full Text] [Related]
25. [Variants of breast lobular neoplasia: differential diagnosis and new molecular insight]. Zhang Z; Zhang Y; Bu H; Tang P Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):160-164. PubMed ID: 35152642 [TBL] [Abstract][Full Text] [Related]
26. The management of lobular neoplasia identified on percutaneous core breast biopsy. Bauer VP; Ditkoff BA; Schnabel F; Brenin D; El-Tamer M; Smith S Breast J; 2003; 9(1):4-9. PubMed ID: 12558663 [TBL] [Abstract][Full Text] [Related]
27. Breast procedures guided by magnetic resonance imaging. David J; Trop I; Lalonde L Can Assoc Radiol J; 2005 Dec; 56(5):309-18. PubMed ID: 16579025 [No Abstract] [Full Text] [Related]
29. Mammographically directed breast biopsies: a College of American Pathologists Q-Probes study of clinical physician expectations and of specimen handling and reporting characteristics in 434 institutions. Nakhleh RE; Jones B; Zarbo RJ Arch Pathol Lab Med; 1997 Jan; 121(1):11-8. PubMed ID: 9111087 [TBL] [Abstract][Full Text] [Related]
30. Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology. Lishman SC; Lakhani SR Histopathology; 1999 Sep; 35(3):195-200. PubMed ID: 10469210 [TBL] [Abstract][Full Text] [Related]
31. Current management of lobular in situ neoplasia. Liebens F; Cardinael AS; Schillings AP; Mendez V; Demoulin C; Cusumano P; Carly B; Faverly D; Rozenberg S JBR-BTR; 2008; 91(4):166-70. PubMed ID: 18817092 [TBL] [Abstract][Full Text] [Related]
32. [What is your diagnosis? Lobular carcinoma in situ (LCIS) in sclerosing adenosis]. Zámecník M Cesk Patol; 2003 Oct; 39(4):174, 195. PubMed ID: 14663928 [No Abstract] [Full Text] [Related]
33. Contemporaneous H&E sections should be standard practice in diagnostic immunopathology. Hoda SA; Rosen PP Am J Surg Pathol; 2007 Oct; 31(10):1627. PubMed ID: 17895767 [No Abstract] [Full Text] [Related]
34. Premalignant and malignant disease of the breast: the roles of the pathologist. Page DL; Jensen RA; Simpson JF Mod Pathol; 1998 Feb; 11(2):120-8. PubMed ID: 9504682 [TBL] [Abstract][Full Text] [Related]
35. Lobular neoplasia diagnosed on breast Core biopsy: frequency of carcinoma on excision and implications for management. Calhoun BC; Collie AM; Lott-Limbach AA; Udoji EN; Sieck LR; Booth CN; Downs-Kelly E Ann Diagn Pathol; 2016 Dec; 25():20-25. PubMed ID: 27806840 [TBL] [Abstract][Full Text] [Related]
36. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Wells JM; Pipa J; Shin SJ Am J Surg Pathol; 2014 Mar; 38(3):434-5. PubMed ID: 24441664 [No Abstract] [Full Text] [Related]
37. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. Goldstein NS; Bassi D; Watts JC; Layfield LJ; Yaziji H; Gown AM Am J Clin Pathol; 2001 Apr; 115(4):534-42. PubMed ID: 11293901 [TBL] [Abstract][Full Text] [Related]
38. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology. Elston CW; Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Dervan P; Drijkoningen M; Eusebi V; Faverly D; Holland R; Jacquemier J; Lacerda M; Martinez-Penuela J; de Miguel C; Mossi S; Munt C; Peterse JL; Rank F; Reiner A; Sylvan M; Wells CA; Zafrani B Eur J Cancer; 2000 Sep; 36(14):1769-72. PubMed ID: 10974624 [TBL] [Abstract][Full Text] [Related]
39. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. Mahoney MC; Robinson-Smith TM; Shaughnessy EA AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141 [TBL] [Abstract][Full Text] [Related]
40. Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy. Donaldson AR; McCarthy C; Goraya S; Pederson HJ; Sturgis CD; Grobmyer SR; Calhoun BC Cancer; 2018 Feb; 124(3):459-465. PubMed ID: 29023647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]